You are here

Impact of Rituximab (Rituxan) on the Treatment of B-Cell Non-Hodgkin’s Lymphoma

Efrat Dotan, MD, Charu Aggarwal, MD, MPH, and Mitchell R. Smith, MD, PhD
PDF version: 
Rituximab prolongs survival in patients with aggressive lymphomas, but more study is needed to clarify its effect on survival of patients with indolent lymphomas.